2024-05-08 10:37:16 ET
Summary
- Pfizer's stock has experienced significant fluctuations in the past 4 years, with opportunities for investors to buy low and sell high.
- The market has driven Pfizer's price to a 10-year low.
- Pfizer's focus on oncology and its strong pipeline of new products position the company for future growth, although debt obligations may limit dividend increases in the short term.
Written by Sam Kovacs.
Introduction
Everyone says they want to buy low and sell high, but for some reason they forget to do so.
Pfizer Inc. ( PFE ) stock has been on a wild ride these past 4 years.
Had you had the foresight to bet on Pfizer in 2020 during the first few months of the pandemic, you would have enjoyed 50% returns within a year or so....
Read the full article on Seeking Alpha
For further details see:
Pfizer: A 6% Yield And At 10-Year Lows